A vaccine for the deadly Ebola virus is being processed in Frederick.
The vaccine is a joint product of the National Institute of Allergy and Infectious Diseases and GlaxoSmithKline. The active ingredients of the vaccine are sent to the Vaccine Pilot Plant on Geoffrey Way, where they are put into vials and prepared for use, according to NIAID.
NIAID spokeswoman Jennifer Routh said the vaccine is "solely being used in clinical trials" at the National Institutes of Health’s Clinical Center in Bethesda.
NIH started testing the vaccine on humans in September.